Cargando…
Empagliflozin in posttransplantation diabetes mellitus: A prospective, interventional pilot study on glucose metabolism, fluid volume, and patient safety
The safety and efficacy of sodium‐glucose cotransporter 2 inhibitors in posttransplantation diabetes mellitus is unknown. We converted stable kidney transplant patients to 10 mg empagliflozin, aiming at replacing their insulin therapy (<40 IU/d). N = 14 participants (the required sample size) com...
Autores principales: | Schwaiger, Elisabeth, Burghart, Lukas, Signorini, Lorenzo, Ristl, Robin, Kopecky, Chantal, Tura, Andrea, Pacini, Giovanni, Wrba, Thomas, Antlanger, Marlies, Schmaldienst, Sabine, Werzowa, Johannes, Säemann, Marcus D., Hecking, Manfred |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590167/ https://www.ncbi.nlm.nih.gov/pubmed/30585690 http://dx.doi.org/10.1111/ajt.15223 |
Ejemplares similares
-
Fluid overload in hemodialysis patients: a cross-sectional study to determine its association with cardiac biomarkers and nutritional status
por: Antlanger, Marlies, et al.
Publicado: (2013) -
Intrarenal Renin-Angiotensin-System Dysregulation after Kidney Transplantation
por: Kovarik, Johannes J., et al.
Publicado: (2019) -
Combined sodium glucose co‐transporter‐2 inhibitor and angiotensin‐converting enzyme inhibition upregulates the renin‐angiotensin system in chronic kidney disease with type 2 diabetes: Results of a randomized, double‐blind, placebo‐controlled exploratory trial
por: Antlanger, Marlies, et al.
Publicado: (2022) -
Blood volume-monitored regulation of ultrafiltration in fluid-overloaded hemodialysis patients: study protocol for a randomized controlled trial
por: Hecking, Manfred, et al.
Publicado: (2012) -
A randomized controlled trial-based algorithm for insulin-pump therapy in hyperglycemic patients early after kidney transplantation
por: Werzowa, Johannes M., et al.
Publicado: (2018)